Comparative substrate specificity study of carboxypeptidase U (TAFIa) and carboxypeptidase N: Development of highly selective CPU substrates as useful tools for assay development

Clinica Chimica Acta

Volumn 387, Issue 1-2, 2008, Pages 158-160

  Willemse, Johan L ^a   Polla, Magnus ^b   Olsson, Thomas ^b   Hendriks, Dirk F ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Carboxypeptidase N; Carboxypeptidase U; Fibrinolysis; Inflammation; TAFI

Indexed keywords

ARGININE CARBOXYPEPTIDASE; ARGININE DERIVATIVE; AROMATIC AMINO ACID; HIPPURYLARGININE; PHENYLALANINE; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; TRYPTOPHAN; TYROSINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; ENZYME ASSAY; ENZYME SPECIFICITY; ENZYME SUBSTRATE COMPLEX; FIBRINOLYSIS; HUMAN; INFLAMMATION; PRIORITY JOURNAL;

CARBOXYPEPTIDASE U; HUMANS; LYSINE CARBOXYPEPTIDASE; SENSITIVITY AND SPECIFICITY; SUBSTRATE SPECIFICITY;

EID: 35748983545     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.09.013     Document Type: Article

References (16)

1. Skidgel R.A. Structure and function of mammalian zinc carboxypeptidases. In: Hooper N.M. (Ed). Zinc metalloproteases in health and disease (1996), Taylor and Francis Ltd, London 241-283
2. Hendriks D., Scharpé S., and van Sande M. Partial characterization of a new arginine carboxypeptidase from human serum. J Clin Chem Clin Biochem 26 (1988) 305
3. Hendriks D.F., and Willemse J.L. Discovery of thrombin activatable fibrinolysis inhibitor (TAFI). J Thromb Haemostasis 4 (2006) 261-262
4. Wang W., Boffa M.B., Bajzar L., Walker J.B., and Nesheim M.E. A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor. J Biol Chem 273 (1988) 27176-27181
5. Schneider M., and Nesheim M. A study of the protection of plasmin from antiplasmin inhibition within an intact fibrin clot during the course of clot lysis. J Biol Chem 279 (2004) 13333-13339
6. Willemse J.L., and Hendriks D.F. A role for procarboxypeptidase U in thrombosis. Front Biosci 12 (2007) 1973-1987
7. Willemse J.L., and Hendriks D.F. Measurement of procarboxypeptidase U (TAFI) in human plasma: a laboratory challenge. Clin Chem 52 (2006) 30-36
8. Boffa M.B., and Koschinsky M.L. Curiouser and curiouser: recent advances in measurement of thrombin-activatable fibrinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and biological roles. Clin Biochem 40 (2007) 431-442
9. Schatteman K., Goossens F., Scharpé S., and Hendriks D. Proteolytic activation of purified procarboxypeptidase U. Clin Chim Acta 292 (2000) 25-40
10. Wang W., Hendriks D., and Scharpé S. Carboxypeptidase U, a plasma carboxypeptidase with high affinity for plasminogen. J Biol Chem 269 (1994) 15937-15944
11. Willemse J.L., Leurs J., Verkerk R., and Hendriks D.F. Development of a fast kinetic method for the determination of carboxypeptidase U (TAFIa) using C-terminal arginine containing peptides as substrate. Anal Biochem 340 (2005) 106-112
12. Willemse J.L., and Hendriks D.F. A rapid and sensitive assay for the quantitation of carboxypeptidase N, an important regulator of inflammation. Clin Chim Acta 371 (2006) 124-129
13. Juillerat-Jeanneret L., Roth M., and Bargetzi J.P. Some properties of porcine carboxypeptidase N. Hoppe-Seyler Z Physiol Chem 363 (1982) 51-58
14. Masuda K., Yoshioka M., Hinode D., and Nakamura R. Purification and characterization of arginine carboxypeptidase produced by Porphyromonas gingivalis. Infect Immun 79 (2002) 1807-1815
15. Deiteren K., Surpateanu G., Gilany K., et al. The role of the S1 binding site of carboxypeptidase M in substrate specificity and turnover. Biochim Biophys Acta 1774 (2007) 267-277
16. Willemse J.L., Leurs J.R., and Hendriks D.F. Fast kinetic assay for the determination of procarboxypeptidase U (TAFI) in human plasma. J Thromb Haemostasis 3 (2005) 2353-2355